v3.26.1
CONDENSED STATEMENTS OF CASH FLOWS - USD ($)
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Operating Activities:    
Net income/(loss) $ (4,003,746) $ (3,739,693)
Adjustments to reconcile net income (loss) to cash used in operating activities:    
Depreciation and amortization 42,427 34,352
Share-based compensation 177,004 615,492
Operating lease asset amortization 301,212 265,343
Amortization of debt discount 0 2,780
Loss on equity method investment 1,066 1,579
Inventory reserve expense 35,372 (8,286)
Gain on settlement of liability, net 0 (35,039)
Changes in operating assets and liabilities:    
Accounts receivable (32,250) (12,821)
Inventories (43,640) 3,508
Prepaid expenses and other current assets (123,536) (134,099)
Accounts payable 24,498 138,146
Operating lease liabilities (328,203) (280,450)
Accrued interest 24,184 24,184
Accrued expenses 116,490 (236,540)
Net cash used in operating activities (3,809,122) (3,361,544)
Investing Activities:    
Payments on purchase of assets 0 (2,515)
Cost investment purchase (200,000) 0
Net cash used in investing activities (200,000) (2,515)
Financing Activities:    
Repayment of bridge loans 0 (22,335)
Proceeds from issuance of Common Stock 9,999,923 3,566,594
Financing issuance cost (799,284) (396,084)
Exercise of warrants 6,931,053 0
Exercised PIPE warrants cost (401,267) 0
Exercised options 30,430 0
Net cash provided by (used in) financing activities 15,760,855 3,148,175
Net change in cash and cash equivalents 11,751,733 (215,884)
Cash and cash equivalents at beginning of period 2,786,493 3,170,743
Cash and cash equivalents at end of period 14,538,226 2,954,859
Supplemental disclosure of cash flow information:    
Interest $ 0 $ 446